United States:
Objective Indicia Of Nonobviousness Overturns PTAB Decision
01 September 2021
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
To print this article, all you need is to be registered or login on Mondaq.com.
In Campbell Soup Co. v. Gamon Plus, Inc., Nos. 20-2344
and 21-1019 (Fed. Cir. Aug. 19, 2021), the Federal Circuit reversed
the Final Written Decisions in two IPRs on design patents,
concluding that the petitioner had not demonstrated the
unpatentability of the claims in view of objective indicia of
nonobviousness. Finnegan's At the PTAB Blog explains the
details of the decision.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
"Patent Marking Regarding Software Medical Devices"
Marshall, Gerstein & Borun LLP
The IPO Law Journal recently published a paper titled "Patent Marking Regarding Software Medical Devices." The paper discusses an overview of patent marking-related case law...